SCHEMBL3967096

SCHEMBL3967096

OCCN1CCN(CCCNc2ncc(Br)c(-c3cc4ccccc4s3)n2)CC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.38
HTR2A P28223 2/20 0.38
HTR7 P34969 2/20 0.38
HTR6 P50406 2/20 0.38
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
IKBKB O14920 1/20 0.37
CHUK O15111 1/20 0.37
IKBKG Q9Y6K9 1/20 0.37
CD274 Q9NZQ7 1/20 0.36
FGFR1 P11362 4/20 0.36
DRD3 P35462 3/20 0.36
EGFR P00533 2/20 0.36
SRC P12931 1/20 0.35
FGFR2 P21802 1/20 0.35
FGFR4 P22455 1/20 0.35
FGFR3 P22607 1/20 0.35
ADORA1 P30542 2/20 0.35
IRAK4 Q9NWZ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3964127 0.91 FGFR1 (0.44) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL3965524 0.91 SLC2A1 (0.42) DRD2HTR2AHTR7HTR6SLC6A2
Hydrochloric Acid SCHEMBL3964469 0.88 MERTK (0.36) DRD2HTR2AHTR7HTR6SLC6A2
Hydrochloric Acid SCHEMBL3965201 0.85 SLC2A1 (0.38) IKBKBCHUKIKBKGCD274FGFR1
Hydrochloric Acid SCHEMBL3970371 0.82 CA1 (0.40) DRD2SLC6A2SLC6A4IKBKBCHUK
Hydrochloric Acid SCHEMBL3967678 0.82 TACR2 (0.38) DRD2HTR2AHTR7HTR6
SCHEMBL3963837 0.81 FGFR1 (0.44) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2983692 0.81 PRKCQ (0.37) IKBKBCHUKIKBKGCD274ADORA1
SCHEMBL3971053 0.80 SLC2A1 (0.43) DRD2HTR2AHTR7HTR6FGFR1
SCHEMBL3966578 0.80 FGFR1 (0.50) FGFR1EGFRSRCFGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed